BRIEF-FDA approves Genentech's MS drug Ocrevus
* FDA approves Genentech's Ocrevus (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis
Nov 22 Celestica Inc
* As per transaction, co has acquired Karel's Manufacturing assets in both Mexicali, Mexico and Calexico, California
* Approximately 400 Karel employees will be joining Celestica from across the Mexico and California operations
* Press release - Celestica expands capabilities for the aerospace market through asset purchase agreement with Karel Manufacturing Source text for Eikon: Further company coverage:
LIMA, March 28 A Boeing jet operated by Peruvian Airlines caught fire on Tuesday while landing at an airport near the Andean town of Jauja in central Peru after it swerved on the runway, but there were no serious injuries, a government minister said.
March 28 The U.S. Food and Drug Administration (FDA) on Tuesday approved Roche Holding AG's multiple sclerosis (MS) drug Ocrevus, putting the potential blockbuster drug back on track after a delay by regulators over manufacturing issues.